相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial
A. Bahl et al.
ANNALS OF ONCOLOGY (2013)
Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
Joachim Weischenfeldt et al.
CANCER CELL (2013)
FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells
Biswajyoti Sahu et al.
CANCER RESEARCH (2013)
Androgen Receptor-Independent Function of FoxA1 in Prostate Cancer Metastasis
Hong-Jian Jin et al.
CANCER RESEARCH (2013)
Aberrant BAF57 Signaling Facilitates Prometastatic Phenotypes
Sucharitha Balasubramaniam et al.
CLINICAL CANCER RESEARCH (2013)
Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes
Michael A. Augello et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
Changmeng Cai et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Enzalutamide: A Novel Anti-androgen with Prolonged Survival Rate in CRPC Patients
Richa Dhingra et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)
ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss
Yu Chen et al.
NATURE MEDICINE (2013)
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
FOXAI mutations in hormone-dependent cancers
Jessica L. L. Robinson et al.
FRONTIERS IN ONCOLOGY (2013)
Diverse functions of ATP-dependent chromatin remodeling complexes in development and cancer
Jiang I. Wu
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2012)
FOXA1 Promotes Tumor Progression in Prostate Cancer and Represents a Novel Hallmark of Castration-Resistant Prostate Cancer
Josefine Gerhardt et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
A Sox9/Fgf feed-forward loop maintains pancreatic organ identity
Philip A. Seymour et al.
DEVELOPMENT (2012)
Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone
Eleni Efstathiou et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Bone Scan Index: A Quantitative Treatment Response Biomarker for Castration-Resistant Metastatic Prostate Cancer
Elizabeth R. Dennis et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Regulation of the androgen receptor by post-translational modifications
Kelly Coffey et al.
JOURNAL OF ENDOCRINOLOGY (2012)
The AR dependent cell cycle: Mechanisms and cancer relevance
Matthew J. Schiewer et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Post-translational modification of the androgen receptor
Daniel Gioeli et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Karim Fizazi et al.
LANCET ONCOLOGY (2012)
Slug, a Unique Androgen-Regulated Transcription Factor, Coordinates Androgen Receptor to Facilitate Castration Resistance in Prostate Cancer
Kaijie Wu et al.
MOLECULAR ENDOCRINOLOGY (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri et al.
NATURE GENETICS (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
Definition of a FoxA1 Cistrome That Is Crucial for G1 to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer
Chunpeng Zhang et al.
CANCER RESEARCH (2011)
Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
Changmeng Cai et al.
CANCER RESEARCH (2011)
Translating Scientific Advancement into Clinical Benefit for Castration-Resistant Prostate Cancer Patients
Gerhardt Attard et al.
CLINICAL CANCER RESEARCH (2011)
Targeting Continued Androgen Receptor Signaling in Prostate Cancer
Christophe Massard et al.
CLINICAL CANCER RESEARCH (2011)
New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway
Gerhardt Attard et al.
CLINICAL CANCER RESEARCH (2011)
A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors
Simon Pacey et al.
CLINICAL CANCER RESEARCH (2011)
FOXA1: master of steroid receptor function in cancer
Michael A. Augello et al.
EMBO JOURNAL (2011)
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Charles E. Massie et al.
EMBO JOURNAL (2011)
Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
Biswajyoti Sahu et al.
EMBO JOURNAL (2011)
Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers
Aurelien A. Serandour et al.
GENOME RESEARCH (2011)
High-level expression of forkhead-box protein A1 in metastatic prostate cancer
Rohit K. Jain et al.
HISTOPATHOLOGY (2011)
Cyclin D1 Is a Selective Modifier of Androgen-dependent Signaling and Androgen Receptor Function
Clay E. S. Comstock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The genomic complexity of primary human prostate cancer
Michael F. Berger et al.
NATURE (2011)
Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine
Kenichiro Furuyama et al.
NATURE GENETICS (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Understanding the role of SOX9 in acquired diseases: lessons from development
James Pritchett et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer
Karen E. Knudsen et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2011)
CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression
Xueqing Sun et al.
CANCER AND METASTASIS REVIEWS (2010)
An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
Jindan Yu et al.
CANCER CELL (2010)
SOX9 Elevation in the Prostate Promotes Proliferation and Cooperates with PTEN Loss to Drive Tumor Formation
Martin K. Thomsen et al.
CANCER RESEARCH (2010)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer
Karen E. Knudsen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines
Modjtaba Emadi Baygi et al.
TUMOR BIOLOGY (2010)
Hijacking the Chromatin Remodeling Machinery: Impact of SWI/SNF Perturbations in Cancer
Bernard Weissman et al.
CANCER RESEARCH (2009)
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Qianben Wang et al.
CELL (2009)
Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer
Chunru Lin et al.
CELL (2009)
Understanding the Words of Chromatin Regulation
Jiang I. Wu et al.
CELL (2009)
Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer
Karen E. Knudsen et al.
CLINICAL CANCER RESEARCH (2009)
Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States
Juan-Miguel Mosquera et al.
CLINICAL CANCER RESEARCH (2009)
Emerging roles of chemokines in prostate cancer
David Vindrieux et al.
ENDOCRINE-RELATED CANCER (2009)
Cistromics of hormone-dependent cancer
Mathieu Lupien et al.
ENDOCRINE-RELATED CANCER (2009)
ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice
Scott A. Tomlins et al.
EUROPEAN UROLOGY (2009)
Coactivator Function Defines the Active Estrogen Receptor Alpha Cistrome
Mathieu Lupien et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Cyclin D1b Variant Promotes Cell Invasiveness Independent of Binding to CDK4 in Human Bladder Cancer Cells
Chul Jang Kim et al.
MOLECULAR CARCINOGENESIS (2009)
Induction of Kruppel-Like Factor 5 Expression by Androgens Results in Increased CXCR4-Dependent Migration of Prostate Cancer Cells in Vitro
Daniel E. Frigo et al.
MOLECULAR ENDOCRINOLOGY (2009)
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
Jennifer C. King et al.
NATURE GENETICS (2009)
Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer
Ram-Shankar Mani et al.
SCIENCE (2009)
Mechanisms mediating androgen receptor reactivation after castration
Xin Yuan et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Outcomes for intermediate risk prostate cancer: Are there advantages for surgery, external radiation, or brachytherapy?
Eric A. Klein et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: Potential role in prostate cancer bone tropism
Whitney L. Jamieson et al.
CANCER RESEARCH (2008)
Targeting the BAF57 SWI/SNF subunit in prostate cancer: A novel platform to control androgen receptor activity
Kevin A. Link et al.
CANCER RESEARCH (2008)
Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists
Ying Wang et al.
CANCER RESEARCH (2008)
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
R. Bruce Montgomery et al.
CANCER RESEARCH (2008)
SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion
Hongyun Wang et al.
CANCER RESEARCH (2008)
Characterization of TMPRSS2 : ETV5 and SLC45A3 : ETV5 gene fusions in prostate cancer
Beth E. Helgeson et al.
CANCER RESEARCH (2008)
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription
Mathieu Lupien et al.
CELL (2008)
Sox9 is required for prostate development
Martin K. Thomsen et al.
DEVELOPMENTAL BIOLOGY (2008)
Pre-receptor regulation of the androgen receptor
Trevor M. Penning et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
The Contribution of Different Androgen Receptor Domains to Receptor Dimerization and Signaling
Margaret M. Centenera et al.
MOLECULAR ENDOCRINOLOGY (2008)
Hormonal approaches in prostate cancer: Application in the contemporary prostate cancer patient
Kathleen W. Beekman et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Testosterone surge: Rationale for gonadotropin-releasing hormone blockers?
Hendrik van Poppel et al.
UROLOGY (2008)
Role of the TMPRSS2-ERG gene fusion in prostate cancer
Arul M. Chinnaiyan
NEOPLASIA (2008)
Recurrent gene fusions in prostate cancer
Chandan Kumar-Sinha et al.
NATURE REVIEWS CANCER (2008)
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome
Jindan Yu et al.
CANCER RESEARCH (2007)
TMPRSS2-ERG fusion heterogeneity in Multifocal prostate cancer: Clinical and biologic implications
Marc Barry et al.
UROLOGY (2007)
Neoadjuvant docetaxel treatment for locally advanced prostate cancer - A clinicopathologic study
Cristina Magi-Galluzzi et al.
CANCER (2007)
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A. Tomlins et al.
NATURE (2007)
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F. Demichelis et al.
ONCOGENE (2007)
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer
Rohit Mehra et al.
MODERN PATHOLOGY (2007)
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology Practice Guideline
D. Andrew Loblaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
SOX9 is required for maintenance of the pancreatic progenitor cell pool
Philip A. Seymour et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Chemotherapy for advanced prostate cancer: Docetaxel and beyond
Robert Dreicer
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2006)
Combined androgen blockade: An update
L Klotz
UROLOGIC CLINICS OF NORTH AMERICA (2006)
Cyclin D1: polymorphism, aberrant splicing and cancer risk
KE Knudsen et al.
ONCOGENE (2006)
Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation
CJ Burd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The cyclin D1b splice variant: an old oncogene learns new tricks
Karen E. Knudsen
CELL DIVISION (2006)
Management of advanced prostate cancer after first-line chemotherapy
DR Berthold et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF
KA Link et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression
CJ Burd et al.
MOLECULAR ENDOCRINOLOGY (2005)
Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo
YX Sun et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
A central domain of cyclin D1 mediates nuclear receptor corepressor activity
CE Petre-Draviam et al.
ONCOGENE (2005)
CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells
SA Shulby et al.
CANCER RESEARCH (2004)
Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development
GR Cunha et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo
YX Sun et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Generation and characterization of androgen receptor knockout (ARKO) mice:: An in vivo model for the study of androgen functions in selective tissues
SY Yeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Twenty pairs of Sox:: Extent, homology, and nomenclature of the mouse and human sox transcription factor gene families
GE Schepers et al.
DEVELOPMENTAL CELL (2002)
Cyclin D1: Mechanism and consequence of androgen receptor co-repressor activity
CE Petre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1
H Umehara et al.
IMMUNOLOGY AND CELL BIOLOGY (2001)
Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone
JS Sack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: Predictive role of bone resorption and formation markers evaluated at baseline
A Berruti et al.
JOURNAL OF UROLOGY (2000)
Structural evidence for ligand specificity in the binding domain of the human androgen receptor -: Implications for pathogenic gene mutations
PM Matias et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms
S Goda et al.
JOURNAL OF IMMUNOLOGY (2000)
Metastatic patterns of prostate cancer:: An autopsy study of 1,589 patients
L Bubendorf et al.
HUMAN PATHOLOGY (2000)
分享论文
